This video features Brenda Banwell, MD of Children's Hospital Philadelphia and was created in 2019 after the approval of Gilenya® in children with MS age ten years and older. Information is accurate as of then. Please visit www.nationalMSsociety.org/meds for the most updated information. To learn more about Gilenya and other disease modifying therapy options, download the Consensus on Disease Modifying Therapies online at www.nationalmssociety.org/DMTconsensus.
